[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572467":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":11,"responsibleParty":32,"collaborators":11,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":11,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":42,"maxAge":43,"enrollmentInfo":44,"targetDuration":11,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":57,"whyStopped":11,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":11},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment education for perinatal women and the womens' community support","EXPERIMENTAL",null,[13],"Other: substance abuse treatment education",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":11},"substance abuse treatment education","Perinatal women and the women's community support will receive a 50 minute education session that provides correct information on opioid agonist medications and neonatal abstinence syndrome.",[9],[20],{"name":21,"affiliation":5,"role":22},"Michael Kidorf, Ph.D.","PRINCIPAL_INVESTIGATOR",[24,28],{"name":21,"role":25,"phone":26,"phoneExt":11,"email":27},"CONTACT","410 550 0006","mkidorf@jhmi.edu",{"name":29,"role":25,"phone":30,"phoneExt":11,"email":31},"Denis Antoine, MD","410 550 7843","antoine@jhmi.edu",{"type":33,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100572467","treatment-education-for-perinatal-women-and-their-community-support-100572467",false,"NCT06733649","Treatment Education for Perinatal Women and Their Community Support","Treatment Education for Pre- and Postpartum Women and Their Community Support","Inclusion Criteria:\n\n* perinatal women treated with agonist medication\n* interest in study participation\n* interest in community support:\n* interest in study participation\n\nExclusion Criteria:\n\n* perinatal women not treated with agonist medication\n* not interested in study participation\n* not interested in community support:\n* not interested in study participation","ALL","18 Years","80 Years",{"count":45,"type":46},80,"ESTIMATED","INTERVENTIONAL",[49],"NA","The study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women with opioid use disorder and a community support person. The education session provides correct information about opioid agonist medications and neonatal abstinence syndrome.",[52],"Opioid Dependency",[54,55,56],"opioid dependence","perinatal women","social support","NOT_YET_RECRUITING","2026-01-09",{"date":60,"type":61},"2026-01-12","ACTUAL",{"date":63,"type":46},"2026-07-06",{"date":65,"type":46},"2027-12-05",{"name":5,"class":6}]